From Casetext: Smarter Legal Research

Techfields Pharma Co. v. Covance, Inc.

United States District Court, D. New Jersey
Sep 17, 2024
Civil Action 16-1148 (RK) (JBD) (D.N.J. Sep. 17, 2024)

Opinion

Civil Action 16-1148 (RK) (JBD)

09-17-2024

TECHFIELDS PHARMA CO., LTD., Plaintiff, v. COVANCE, INC., et al., Defendants.


MEMORANDUM ORDER

ROBERT KIRSCH, UNITED STATES DISTRICT JUDGE

THIS MATTER comes before the Court upon a letter from Defendants Covance, Inc. and Fisher Clinical Services, Inc. (collectively, “Defendants”) requesting supplemental Daubert briefing and oral argument, (ECF No. 346), in connection with Defendants' motions to exclude the testimony of Plaintiff's damages expert, Mr. Jeffrey B. Baresciano, (ECF Nos. 205, 209). Plaintiff Techfields Pharma Co., Ltd. (“Plaintiff') wrote to the Court in opposition to Defendants' request, (ECF No. 347), and Defendants replied, (ECF No. 351). After considering the parties' submissions, and recognizing district courts' “inherent authority to manage their dockets and courtrooms with a view toward the efficient and expedient resolution of cases,” Dietz v. Bouldin, 579 U.S. 40, 47 (2016), IT IS on this 17th day of September, 2024, ORDERED that Defendants' request for supplemental Daubert briefing and oral argument is DENIED.)


Summaries of

Techfields Pharma Co. v. Covance, Inc.

United States District Court, D. New Jersey
Sep 17, 2024
Civil Action 16-1148 (RK) (JBD) (D.N.J. Sep. 17, 2024)
Case details for

Techfields Pharma Co. v. Covance, Inc.

Case Details

Full title:TECHFIELDS PHARMA CO., LTD., Plaintiff, v. COVANCE, INC., et al.…

Court:United States District Court, D. New Jersey

Date published: Sep 17, 2024

Citations

Civil Action 16-1148 (RK) (JBD) (D.N.J. Sep. 17, 2024)